Histopathological Evaluation of the Effect of Dextromethorphan and Guaifenesin on the Lung And Kidney Tissues in Albino Rats

Authors

  • Momodu Edo State University Author
  • Oseni Akhere Edo State University Author
  • Iyare Godfrey Innocent Edo State University Author
  • Avwioro Godwin Ovie Delta State University Author

DOI:

https://doi.org/10.59890/k1bwvd23

Keywords:

Histopathological Evaluation, Effect, Guaifenesin, Kidney Tissues

Abstract

Dextromethorphan and guaifenesin are two commonly used medications for the treatment of cough and colds. While their efficacy in alleviating respiratory symptoms is well documented, comprehensive data on their histopathological impact on vital organs is limited. This study determined the effect of the drugs on the lungs and kidney tissues of Albino rats. Twenty four adult albino rats weighing 110±20g were grouped into 4, of 6 rats each. Group A received only normal feed and water daily and served as the control. Groups B, C and D were administered with 0.1ml, 0.5ml and 1ml respectively with oral dextromethorphan and guaifenesin for 28 days. Blood was collected into lithium heparin for biochemical analysis, while the liver and kidney tissues were fixed in 10% formol saline, processed by the paraffin wax method and stained with H&E for examination. Biochemical analysis showed no significant changes in the values of total protein, albumin and Malondialdehyde, while there was a reduction in the values globulin from 8.10 ± 0.59 to 3.85 ± 2.56, glutathione increased from 112.64 to 462.03 ± 1.88 in the low and high doses. Histological findings showed no significant alterations in lungs and kidney tissues

References

Albrecht, H. H., Dicpinigaitis, P. V., & Guenin, E. P. (2017). Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections. Multidisciplinary Respiratory Medicine, 12, 1-11.

Bezerra, F. S., Lanzetti, M., Nesi, R. T., Nagato, A. C., Silva, C. P. E., Kennedy-Feitosa, E., ... and Valenca, S. S. (2023). Oxidative stress and inflammation in acute and chronic lung injuries. Antioxidants, 12(3), 548.z.

Blenkinsopp, A., Duerden, M., and Blenkinsopp, J. (2022). Symptoms in the pharmacy: a guide to the management of common illnesses. John Wiley and Sons.

Chu, Y. H., Pang, B. Y., Yang, M., Meng, Q., & Leng, Y. (2024). The intervention of curcumin on rodent models of hepatic fibrosis: A systematic review and meta-analysis. Plos one, 19(5), e0304176.

Collins, J. C., and Moles, R. J. (2019). Management of respiratory disorders and the pharmacist's role: cough, colds, and sore throats and allergies (including eyes). Encyclopedia of Pharmacy Practice and Clinical Pharmacy, 282.

Eccles, R. (2020). What is the role of over 100 excipients in over the counter (OTC) cough medicines?. Lung, 198(5), 727-734.

Farah, F. H. (2020). Pharmacovigilance Implications of some inactive Pharmaceutical Ingredients. Research Journal of Pharmacy and Technology, 13(11), 5493-5496.

Gupta, P. K., and Gupta, P. K. (2020). Target organ toxicity. Problem Solving Questions in Toxicology: A Study Guide for the Board and other Examinations, 83-117.

Kandiwa, K. T., Thom, L., & Schellack, N. (2022). A modern approach to cough management. SA Pharmaceutical Journal, 89(4), 25-29.

Kayode, A. A., Kayode, O. T., & Oridota, O. J. (2021). Alterations in the biochemical indices in Wistar rats exposed to an overdose of codeine and dextromethorphan. Journal of Taibah University Medical Sciences, 16(2), 198-208.

Lu, Y., Zhang, Y., Xu, D., Wang, Y., Pan, D., Xia, H., & Sun, G. (2022). Long course of low-dose dexamethasone following or after bleomycin administration ameliorates pulmonary fibrosis. International Immunopharmacology, 113, 109465.

Lund, C., Ranea-Robles, P., Falk, S., Rausch, D. M., Skovbjerg, G., Vibe-Petersen, V. K., ... & Clemmensen, C. (2024). Protection against overfeeding-induced weight gain is preserved in obesity but does not require FGF21 or MC4R. Nature Communications, 15(1), 1192.

Manti, S., Tosca, M. A., Licari, A., Brambilla, I., Foiadelli, T., Ciprandi, G., and Marseglia, G. L. (2020). Cough remedies for children and adolescents: current and future perspectives. Pediatric Drugs, 22, 617-634.

Nigam, S. K., and Bush, K. T. (2019). Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling. Nature Reviews Nephrology, 15(5), 301-316.

Ohar, J. A., Donohue, J. F., & Spangenthal, S. (2019). The role of guaifenesin in the management of chronic mucus hypersecretion associated with stable chronic bronchitis: a comprehensive review. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, 6(4), 341.

Okamoto, K., Hashimoto, N., Ishizeki, K., Nishimura, T., Makino, S., Takashima, A., ... & Hayashi, T. (2025). Dextromethorphan-induced serotonin syndrome leading to rhabdomyolysis and dialysis-requiring acute kidney injury: a case report and review. Renal Replacement Therapy, 11(1), 23.

Oladipo, O. O., Ayo, J. O., Ambali, S. F., & Mohammed, B. (2016). Evaluation of hepatorenal impairments in Wistar rats coexposed to low-dose lead, cadmium and manganese: insights into oxidative stress mechanism. Toxicology mechanisms and methods, 26(9), 674-684.

Rouaz, K., Chiclana-Rodríguez, B., Nardi-Ricart, A., Suñé-Pou, M., Mercadé-Frutos, D., Suñé-Negre, J. M., ... and García-Montoya, E. (2021). Excipients in the paediatric population: A review. Pharmaceutics, 13(3), 387.

Shallangwa, S. M., Ross, A. W., & Morgan, P. J. (2025). Single, but not mixed dietary fibers suppress body weight gain and adiposity in high fat-fed mice. Frontiers in Microbiology, 16, 1544433.

Downloads

Published

2025-07-30

Issue

Section

Articles

How to Cite

Histopathological Evaluation of the Effect of Dextromethorphan and Guaifenesin on the Lung And Kidney Tissues in Albino Rats. (2025). Multitech Journal of Science and Technology (MJST), 2(6), 379-388. https://doi.org/10.59890/k1bwvd23